NEUCA S.A. (PL:NEU)

:NEU

NEU

NEUCA S.A.

RESEARCH TOOLSreports

Want to see PL:NEU full AI Analyst Report?

NEUCA S.A. (NEU) Price & Analysis

3 Followers

NEU Stock Chart & Stats

zł844.00

Market closed

zł844.00

Day’s Range― - ―

52-Week Rangezł645.00 - zł857.00

Previous CloseN/A

VolumeN/A

Average Volume (3M)1.23K

Market Cap

zł3.32B

Enterprise Valuezł3.97B

Total Cash (Recent Filing)zł168.62M

Total Debt (Recent Filing)zł853.32M

Price to Earnings (P/E)23.7

Beta0.52

Next Earnings

May 21, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield1.95%

Share Statistics

EPS (TTM)6.01

Shares Outstanding4,626,044

10 Day Avg. Volume1,049

30 Day Avg. Volume1,226

Financial Highlights & Ratios

PEG Ratio-31.54

Price to Book (P/B)3.49

Price to Sales (P/S)0.27

P/FCF Ratio9.94

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)45.86

Revenue Forecast (FY)zł14.31B

Bulls Say, Bears Say

Bulls Say

Stable MarginsStable margins indicate effective cost management and pricing strategies, supporting NEUCA's profitability and operational efficiency over time.

Market PositionAs a market leader in pharmaceutical distribution, NEUCA benefits from established relationships and a strong reputation, providing a durable competitive advantage.

Revenue GrowthConsistent revenue growth showcases NEUCA's ability to maintain its market position and adapt to industry demands, ensuring long-term business sustainability.

Bears Say

Earnings GrowthNegative EPS growth reflects challenges in maintaining earnings momentum, which could impact NEUCA's ability to reinvest in its business and sustain shareholder returns.

Profitability DeclineA decline in profitability metrics like ROE may indicate challenges in generating returns from equity, potentially affecting investor confidence and future growth.

Cash Flow ManagementWeak cash flow management can limit NEUCA's ability to invest in growth opportunities and meet financial obligations, posing a risk to long-term liquidity.

NEU FAQ

What was NEUCA S.A.’s price range in the past 12 months?

NEUCA S.A. lowest stock price was zł645.00 and its highest was zł857.00 in the past 12 months.

What is NEUCA S.A.’s market cap?

NEUCA S.A.’s market cap is zł3.32B.

When is NEUCA S.A.’s upcoming earnings report date?

NEUCA S.A.’s upcoming earnings report date is May 21, 2026 which is in 21 days.

How were NEUCA S.A.’s earnings last quarter?

NEUCA S.A. released its earnings results on Mar 26, 2026. The company reported zł6.011 earnings per share for the quarter, beating the consensus estimate of N/A by zł6.011.

Is NEUCA S.A. overvalued?

According to Wall Street analysts NEUCA S.A.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does NEUCA S.A. pay dividends?

NEUCA S.A. pays a Annually dividend of zł16 which represents an annual dividend yield of 1.95%. See more information on NEUCA S.A. dividends here

What is NEUCA S.A.’s EPS estimate?

NEUCA S.A.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does NEUCA S.A. have?

NEUCA S.A. has 4,626,044 shares outstanding.

What happened to NEUCA S.A.’s price movement after its last earnings report?

NEUCA S.A. reported an EPS of zł6.011 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -6.18%.

Which hedge fund is a major shareholder of NEUCA S.A.?

Currently, no hedge funds are holding shares in PL:NEU

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

NEUCA S.A.

NEUCA S.A. engages in the distribution of pharmaceuticals to pharmacies and hospitals in Poland. It operates through Pharmaceutical Wholesale; Own Brands; and Outpatient Care Clinics, Clinical Trials and Telemedicine segments. The company also provides advertising and marketing services; pharmaceutical products under its own brand; clinical trial, telemedicine, agency, financial, road cargo transport, accounting and bookkeeping, software, hospital, and information technology and computer related services; and health, property, and other personal insurance products. In addition, it operates outpatient care clinics and medical stores. The company was formerly known as Torfarm SA and changed its name to NEUCA S.A. in April 2010. NEUCA S.A. was founded in 1990 and is based in Torun, Poland.